Download PDF
Horm Metab Res 2023; 55(11): 794-800
DOI: 10.1055/a-2111-3821
Original Article: Endocrine Research

Aberrantly Expressed lncRNA LINC00847 May Serve as a Promising Prognostic Factor for Thyroid Cancer

Guoli Hei‡
1   Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
,
Yan Yu‡
2   Outpatient, Huai’an No 4 People’s Hospital, Huai’an, China
,
Yang Wu
3   General Surgery (Thyroid Gland/Blood Vessel), The First People’s Hospital of Neijiang, Neijiang, China
,
Jianyuan Huang
3   General Surgery (Thyroid Gland/Blood Vessel), The First People’s Hospital of Neijiang, Neijiang, China
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Thyroid cancer is a tumor that occurs in the head and neck, which originates from the thyroid follicular epithelial cells. The current research is discussed and elaborated from the perspective of molecular prognostic biomarkers to gain a deeper understanding of the molecular mechanism of thyroid cancer and to provide more effective treatment and prognostic methods for patients. Thyroid cancer patients were explored from histological, cellular and clinical levels. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression of LINC00847 and miR-146b-5p in the tissues and cells of the subjects. Cell growth and thyroid cancer progression were determined by the cell counting kit-8 (CCK-8) and transwell assays. The LINC00847 sponge miR-146b-5p was assessed by bioinformatics tools and luciferase reporter assay, and the Kaplan–Meier method and multivariate Cox regression analysis suggested the prognostic value of high expression of LINC00847. In thyroid cancer tissues and cells, the expression of LINC00847 was decreased. Overexpression of LINC00847 remarkably inhibited the proliferation level, migration ability and invasion ability of thyroid cancer cells. Besides, miR-146b-5p was upregulated in thyroid cancer tissues and cells. It was confirmed that LINC00847 targeting miR-146b-5p had a regulatory effect on the progression of thyroid cancer, and LINC00847 was negatively correlated with miR-146b-5p. LINC00847 may be considered a meaningful prognostic marker to influence tumor growth through sponge miR-146b-5p, which provides a new basis for the prognosis and treatment of thyroid cancer.

Key words

thyroid cancer - lncRNA LINC00847 - miR-146b-5p - prognostic factor


Publication History

Received: 08 March 2023

Accepted after revision: 07 June 2023

Article published online:
06 July 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Bao WQ, Zi H, Yuan QQ. et al. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019. Thorac Cancer 2021; 12: 2494-2503
    CrossrefPubMedGoogle Scholar
  • 2 Faria M, Capinha L, Simões-Pereira J. et al. Extending the impact of RAC1b overexpression to follicular thyroid carcinomas. Int J Endocrinol 2016; 1972367: 1-6
    CrossrefPubMedGoogle Scholar
  • 3 Huang M, Yan C, Wei H. et al. Clinicopathological characteristics and prognosis of thyroid cancer in northwest China: a population-based retrospective study of 2490 patients. Thorac Cancer 2018; 9: 1453-1460
    CrossrefPubMedGoogle Scholar
  • 4 Wang HH, Ma JN, Zhan XR. Circular RNA Circ_0067934 attenuates ferroptosis of thyroid cancer cells by miR-545-3p/SLC7A11 signaling. Front Endocrinol (Lausanne) 2021; 12: 670031
    CrossrefPubMedGoogle Scholar
  • 5 Wu Z, Han L, Li W. et al. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?. Cancer Med 2021; 10: 1614-1622
    CrossrefPubMedGoogle Scholar
  • 6 Hattori S, Yamane Y, Shimomura R. et al. Carney complex: a case with thyroid follicular adenoma without a PRKAR1A mutation. Surg Case Rep 2018; 4: 34
    CrossrefPubMedGoogle Scholar
  • 7 Bener A, Özdenkaya Y, Barışık CC. et al. The impact of metabolic syndrome on increased risk of thyroid nodules and size. Health Serv Res Manag Epidemiol 2018; 5: 2333392818775517
    PubMedGoogle Scholar
  • 8 Wang J, Su Z, Lu S. et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta 2018; 485: 229-233
    CrossrefPubMedGoogle Scholar
  • 9 Xing C, Sun SG, Yue ZQ. et al. Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother 2021; 134: 111158
    CrossrefPubMedGoogle Scholar
  • 10 Zhen Q, Gao LN, Wang RF. et al. LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control 2018; 25: 1073274818769849
    CrossrefPubMedGoogle Scholar
  • 11 Sha W, Liu M, Sun D. et al. Resveratrol improves Gly-LDL-induced vascular endothelial cell apoptosis, inflammatory factor secretion and oxidative stress by regulating miR-142-3p and regulating SPRED2-mediated autophagy. Aging (Albany NY) 2021; 13: 6878-6889
    CrossrefPubMedGoogle Scholar
  • 12 Li H, Chen YK, Wan Q. et al. Long non-coding RNA LINC00847 induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a/IFITM1 axis. Front Med (Lausanne) 2021; 8: 663558
    CrossrefPubMedGoogle Scholar
  • 13 Tu LR, Li W, Liu J. et al. LncRNA LINC00847 contributes to hepatocellular carcinoma progression by acting as a sponge of miR-99a to induce E2F2 expression. J Biol Regul Homeost Agents 2020; 34: 2195-2203
    PubMedGoogle Scholar
  • 14 Safarpour-Dehkordi M, Doosti A, Jami MS. Integrative analysis of lncRNAs in kidney cancer to discover a new lncRNA (LINC00847) as a therapeutic target for staphylococcal enterotoxin tst gene. Cell J 2020; 22: 101-109
    PubMedGoogle Scholar
  • 15 Li W, Hu X, Huang X. Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis. Bioengineered 2022; 13: 9987-10000
    CrossrefPubMedGoogle Scholar
  • 16 Tan Q, Tan Z, Liu J. et al. Integrated bioinformatic analysis of competing endogenous RNA network of choriocarcinoma. Med Sci Monit 2021; 27: e931475
    PubMedGoogle Scholar
  • 17 Jiang Z, Zhang Y, Cao R. et al. miR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5. Oncol Res 2017; 25: 1081-1087
    CrossrefPubMedGoogle Scholar
  • 18 Liu X, Fu Q, Bian X. et al. Long non-coding RNA MAPK8IP1P2 inhibits lymphatic metastasis of thyroid cancer by activating hippo signaling via sponging miR-146b-3p. Front Oncol 2020; 10: 600927
    CrossrefPubMedGoogle Scholar
  • 19 Jonczyk AW, Piotrowska-Tomala KK, Skarzynski DJ. Comparison of intra-CL injection and peripheral application of prostaglandin F(2α) analog on luteal blood flow and secretory function of the bovine corpus luteum. Front Vet Sci 2021; 8: 811809
    CrossrefPubMedGoogle Scholar
  • 20 Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet 2016; 388: 2783-2795
    CrossrefPubMedGoogle Scholar
  • 21 Hatipoğlu F, Karapolat İ, Ömür Ö. et al. Recurrence incidence in differentiated thyroid cancers and the importance of diagnostic iodine-131 scintigraphy in clinical follow-up. Mol Imaging Radionucl Ther 2016; 25: 85-90
    CrossrefPubMedGoogle Scholar
  • 22 Liu H, Deng H, Zhao Y. et al. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res 2018; 37: 279
    CrossrefPubMedGoogle Scholar
  • 23 Yuan J, Song Y, Pan W. et al. LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5. Oncogene 2020; 39: 6664-6676
    CrossrefPubMedGoogle Scholar
  • 24 Wang XM, Liu Y, Fan YX. et al. LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway. Cancer Biol Ther 2018; 19: 590-597
    CrossrefPubMedGoogle Scholar
  • 25 Zhang X, Zhang X, Jia Q. et al. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. BMC Cancer 2022; 22: 344
    CrossrefPubMedGoogle Scholar
  • 26 Qin Y, Sun W, Zhang H. et al. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer. Endocrine 2018; 59: 555-564
    CrossrefPubMedGoogle Scholar
  • 27 Tong C, Wang C, Wang Y. et al. TNRC6C-AS1 Promotes thyroid cancer progression by upregulating LPAR5 via miR-513c-5p. Cancer Manag Res 2021; 13: 6141-6155
    CrossrefPubMedGoogle Scholar
  • 28 Wu C, Su J, Long W. et al. LINC00470 promotes tumour proliferation and invasion, and attenuates chemosensitivity through the LINC00470/miR-134/Myc/ABCC1 axis in glioma. J Cell Mol Med 2020; 24: 12094-12106
    CrossrefPubMedGoogle Scholar
  • 29 Barros-Filho MC, Pewarchuk M, Minatel BC. et al. Previously undescribed thyroid-specific miRNA sequences in papillary thyroid carcinoma. J Hum Genet 2019; 64: 505-508
    CrossrefPubMedGoogle Scholar
  • 30 Boufraqech M, Klubo-Gwiezdzinska J, Kebebew E. MicroRNAs in the thyroid. Best Pract Res Clin Endocrinol Metab 2016; 30: 603-619
    CrossrefPubMedGoogle Scholar
  • 31 Peng Y, Fang X, Yao H. et al. MiR-146b-5p regulates the expression of long noncoding RNA MALAT1 and its effect on the invasion and proliferation of papillary thyroid cancer. Cancer Biother Radiopharm 2021; 36: 433-440
    PubMedGoogle Scholar
  • 32 Di W, Zhang W, Zhu B. et al. Colorectal cancer prompted adipose tissue browning and cancer cachexia through transferring exosomal miR-146b-5p. J Cell Physiol 2021; 236: 5399-5410
    CrossrefPubMedGoogle Scholar
  • 33 Jian Y, Fan Q. Long non-coding RNA SNHG7 facilitates pancreatic cancer progression by regulating the miR-146b-5p/Robo1 axis. Exp Ther Med 2021; 21: 398
    CrossrefPubMedGoogle Scholar
  • 34 Dai R, Jiang Q, Zhou Y. et al. Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT/STAT3/NF-kB signaling. Cancer Cell Int 2021; 21: 408
    CrossrefPubMedGoogle Scholar
  • 35 Li Y, Zhang H, Dong Y. et al. MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer. J Cancer 2017; 8: 1704-1716
    CrossrefPubMedGoogle Scholar
  • 36 Geraldo MV, Yamashita AS, Kimura ET. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Oncogene 2012; 31: 1910-1922
    CrossrefPubMedGoogle Scholar